GH logo

Guardant Health (GH) EBIT

annual EBIT:

-$432.51M+$43.68M(+9.17%)
December 31, 2024

Summary

  • As of today (May 29, 2025), GH annual earnings before interest & taxes is -$432.51 million, with the most recent change of +$43.68 million (+9.17%) on December 31, 2024.
  • During the last 3 years, GH annual EBIT has fallen by -$50.62 million (-13.25%).
  • GH annual EBIT is now -903.15% below its all-time high of -$43.12 million, reached on December 31, 2016.

Performance

GH EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGHincome statement metrics

quarterly EBIT:

-$94.08M+$15.57M(+14.20%)
March 31, 2025

Summary

  • As of today (May 29, 2025), GH quarterly earnings before interest & taxes is -$94.08 million, with the most recent change of +$15.57 million (+14.20%) on March 31, 2025.
  • Over the past year, GH quarterly EBIT has increased by +$19.86 million (+17.43%).
  • GH quarterly EBIT is now -669.87% below its all-time high of -$12.22 million, reached on June 30, 2019.

Performance

GH quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGHincome statement metrics

TTM EBIT:

-$412.65M+$19.86M(+4.59%)
March 31, 2025

Summary

  • As of today (May 29, 2025), GH TTM earnings before interest & taxes is -$412.65 million, with the most recent change of +$19.86 million (+4.59%) on March 31, 2025.
  • Over the past year, GH TTM EBIT has increased by +$44.82 million (+9.80%).
  • GH TTM EBIT is now -1358.80% below its all-time high of -$28.29 million, reached on September 30, 2017.

Performance

GH TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGHincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

GH EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+9.2%+17.4%+9.8%
3 y3 years-13.3%+23.3%-3.7%
5 y5 years-531.0%-195.8%-420.3%

GH EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-13.3%+33.5%-31.3%+58.8%-3.7%+37.6%
5 y5-year-531.0%+33.5%-195.8%+58.8%-420.3%+37.6%
alltimeall time-903.1%+33.5%-669.9%+58.8%-1358.8%+37.6%

GH EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$94.08M(-14.2%)
-$412.65M(-4.6%)
Dec 2024
-$432.51M(-9.2%)
-$109.64M(+2.4%)
-$432.51M(-15.2%)
Sep 2024
-
-$107.08M(+5.1%)
-$509.80M(+4.5%)
Jun 2024
-
-$101.85M(-10.6%)
-$487.69M(+6.6%)
Mar 2024
-
-$113.94M(-39.1%)
-$457.47M(-3.9%)
Dec 2023
-$476.19M(-26.8%)
-$186.94M(+120.0%)
-$476.19M(+11.3%)
Sep 2023
-
-$84.97M(+18.6%)
-$427.94M(-15.1%)
Jun 2023
-
-$71.63M(-46.0%)
-$504.20M(-23.7%)
Mar 2023
-
-$132.65M(-4.4%)
-$660.91M(+1.5%)
Dec 2022
-$650.87M(+70.4%)
-$138.69M(-14.0%)
-$650.87M(+11.5%)
Sep 2022
-
-$161.24M(-29.4%)
-$583.84M(+10.3%)
Jun 2022
-
-$228.34M(+86.2%)
-$529.39M(+33.0%)
Mar 2022
-
-$122.61M(+71.1%)
-$397.90M(+4.2%)
Dec 2021
-$381.89M
-$71.66M(-32.9%)
-$381.89M(-4.1%)
Sep 2021
-
-$106.79M(+10.3%)
-$398.28M(+9.7%)
Jun 2021
-
-$96.85M(-9.1%)
-$363.09M(+14.9%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$106.60M(+21.1%)
-$315.94M(+31.0%)
Dec 2020
-$241.14M(+251.8%)
-$88.05M(+23.0%)
-$241.14M(+37.5%)
Sep 2020
-
-$71.59M(+44.1%)
-$175.37M(+50.2%)
Jun 2020
-
-$49.70M(+56.3%)
-$116.79M(+47.2%)
Mar 2020
-
-$31.80M(+42.8%)
-$79.31M(+15.7%)
Dec 2019
-$68.54M(-17.4%)
-$22.28M(+71.2%)
-$68.54M(-3.7%)
Sep 2019
-
-$13.01M(+6.5%)
-$71.20M(-12.5%)
Jun 2019
-
-$12.22M(-41.9%)
-$81.39M(-10.1%)
Mar 2019
-
-$21.03M(-15.7%)
-$90.49M(+9.1%)
Dec 2018
-$82.97M(+3.1%)
-$24.94M(+7.5%)
-$82.97M(+14.0%)
Sep 2018
-
-$23.20M(+8.8%)
-$72.78M(-6.5%)
Jun 2018
-
-$21.32M(+57.8%)
-$77.87M(+37.7%)
Mar 2018
-
-$13.51M(-8.4%)
-$56.55M(+31.4%)
Dec 2017
-$80.51M(+86.7%)
-$14.75M(-47.9%)
-$43.04M(+52.1%)
Sep 2017
-
-$28.29M
-$28.29M
Dec 2016
-$43.12M
-
-

FAQ

  • What is Guardant Health annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Guardant Health?
  • What is Guardant Health annual EBIT year-on-year change?
  • What is Guardant Health quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Guardant Health?
  • What is Guardant Health quarterly EBIT year-on-year change?
  • What is Guardant Health TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Guardant Health?
  • What is Guardant Health TTM EBIT year-on-year change?

What is Guardant Health annual earnings before interest & taxes?

The current annual EBIT of GH is -$432.51M

What is the all time high annual EBIT for Guardant Health?

Guardant Health all-time high annual earnings before interest & taxes is -$43.12M

What is Guardant Health annual EBIT year-on-year change?

Over the past year, GH annual earnings before interest & taxes has changed by +$43.68M (+9.17%)

What is Guardant Health quarterly earnings before interest & taxes?

The current quarterly EBIT of GH is -$94.08M

What is the all time high quarterly EBIT for Guardant Health?

Guardant Health all-time high quarterly earnings before interest & taxes is -$12.22M

What is Guardant Health quarterly EBIT year-on-year change?

Over the past year, GH quarterly earnings before interest & taxes has changed by +$19.86M (+17.43%)

What is Guardant Health TTM earnings before interest & taxes?

The current TTM EBIT of GH is -$412.65M

What is the all time high TTM EBIT for Guardant Health?

Guardant Health all-time high TTM earnings before interest & taxes is -$28.29M

What is Guardant Health TTM EBIT year-on-year change?

Over the past year, GH TTM earnings before interest & taxes has changed by +$44.82M (+9.80%)
On this page